ATXN3 and malignant colon neoplasm: Indeed, the targeted deletion of ATXN3 in human colon cancer cells, leading to a substantial reduction in Galectin-9, markedly intensified both HCT116 and MC38 colon cancer cell proliferation (Fig. 4, A and B).